Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

808
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
808
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

633
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
633
Complementation Tests00:49

Complementation Tests

5.0K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
5.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[<sup>177</sup>Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange.

International journal of biological macromolecules·2026
Same author

Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.

Science translational medicine·2026
Same author

Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer.

Nuclear medicine communications·2026
Same author

Fusions4U: a resource of validated and annotated gene fusions in 328 cancer cell lines.

BMC cancer·2025
Same author

Evaluation of CD44v6-targeted radionuclide therapy on bone marrow, skin and esophageal epithelium using a novel internal dosimetry model.

Physics in medicine and biology·2025
Same journal

Sub1 contributes to heart failure with preserved ejection fraction driven by aging in mice.

Nature communications·2026
Same journal

The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells.

Nature communications·2026
Same journal

Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.

Nature communications·2026
Same journal

Click-polymerized polyenamine membranes for efficient lithium extraction.

Nature communications·2026
Same journal

Joint trajectories of brain atrophy, white matter hyperintensities and cognition quantify brain maintenance.

Nature communications·2026
Same journal

Proton shuttling at electrochemical interfaces under alkaline hydrogen evolution.

Nature communications·2026
查看所有相关文章

相关实验视频

Updated: Jul 19, 2025

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
08:04

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

11.8K

确定互补性的区域聚类可能会导致CAR-T细胞功能障碍.

Tina Sarén1, Giulia Saronio1, Paula Marti Torrell1

  • 1Uppsala University, Dept Immunology, Genetics, Pathology, Science for Life Laboratory, Uppsala, Sweden.

Nature communications
|August 10, 2023
PubMed
概括
此摘要是机器生成的。

CAR-T细胞治疗设计受到CDR循环的挑战,导致CAR集群. 这导致抗原独立的T细胞激活和功能障碍,影响癌症治疗的疗效.

更多相关视频

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.4K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K

相关实验视频

Last Updated: Jul 19, 2025

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
08:04

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

11.8K
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.4K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K

科学领域:

  • 免疫学 免疫学 免疫学
  • 癌症生物学 癌症生物学
  • 生物技术是生物技术.

背景情况:

  • 化学抗原受体 (CAR) -T细胞疗法在癌症治疗方面表现有前途.
  • 设计最佳的CAR是复杂的,单链变量片段 (scFvs) 通过互补性确定区域 (CDR) 定义特异性.

研究的目的:

  • 研究CDR循环对CAR集群和T细胞功能的影响.
  • 为了确定抗原独立的CAR-T细胞激活和功能障碍的机制.

主要方法:

  • 具有相同框架但不同的CDR序列的工程CAR.
  • 评估了T细胞表面上的CAR集群.
  • 测量了抗原独立的T细胞激活标志物 (细胞大小,IFN-γ分泌).
  • 评估了CAR-T细胞耗尽,细胞死亡和瘤细胞响应能力.

主要成果:

  • 发现CDR循环在T细胞表面中介于CAR集群.
  • CAR聚类诱导了抗原独立的T细胞激活,由细胞大小增加和IFN-γ分泌物证明.
  • 这种增强信号导致CAR-T细胞耗尽,激活诱导的细胞死亡和减少抗瘤活性.

结论:

  • 抗原独立的增强信号可以通过CDR介导的CAR集群触发.
  • 这种现象仅仅通过scFv序列无法预测,但会影响CAR-T细胞的疗效.
  • 评估未刺激的CAR-T细胞活动对于预测治疗结果至关重要.